Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse colon organoids treated with inflammatory reagents.

ABSTRACT: Mouse colon organoids treated with inflammatory reagents.

PROVIDER: PRJNA641669 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression of mouse colon organoids treated with inflammatory reagents.

Project description:Microarray analysis of mouse colon organoids after treatment with the mixture of inflammatory reagents.

2020-06-25 | GSE153176 | GEO

Gene expression of mouse colon organoids treated with inflammatory reagents.

Project description:Gene expression of mouse colon organoids treated with inflammatory reagents.

| PRJNA641674 | ENA

Gene expression of mouse colon organoids after the removal of inflammatory reagents.

Project description:Microarray analysis of mouse colon organoids after the removal of inflammatory reagents following long-term treatment with inflammatory reagents.

2020-06-25 | GSE153175 | GEO

Gene expression of mouse colon organoids after the removal of inflammatory reagents.

Project description:Gene expression of mouse colon organoids after the removal of inflammatory reagents.

| PRJNA641673 | ENA

Red Algae-Derived Mineral Intervention to Counter Pro-inflammatory Activity in Human Colon Organoids

Project description:Human colon organoids were maintained in culture medium alone or exposed to lipopolysaccharide with a combination of three pro-inflammatory cytokines (tumor necrosis factor-a, interleukin-1b and interferon-g [LPS-cytokines]) to mimic the environment in the inflamed colon. Untreated organoids and those exposed to LPS-cytokines were concomitantly treated with a multi-mineral product that has previously been shown to improve barrier structure/function. The organoids were subjected to proteomic analysis to obtain a broad view of the protein changes induced by these interventions. In parallel, confocal fluorescence microscopy and trans-epithelial electrical resistance measurements were used to assess barrier structure/function. The LPS-cytokines altered expression of multiple proteins that influence innate immunity and promote inflammation. Most of these were unaffected by the multi-mineral intervention, though a subset of inflammation-related proteins including fibrinogen-b and -g chains, phospholipase A2 and SPARC was down-regulated in the presence of the multi-mineral intervention; another subset of proteins with anti-inflammatory, antioxidant or anti-microbial activity was up-regulated by multi-mineral treatment. When used alone, the multi-mineral intervention strongly up-regulated proteins that contribute to barrier formation and tissue strength. Concomitant treatment with LPS-cytokines did not inhibit barrier formation in response to the multi-mineral intervention.

2023-06-30 | PXD038941 | Pride

Mouse colon organoids treated with inflammatory reagents.

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-06-25 | GSE153178 | GEO

RNA sequencing of norepinephrine- or vehicle-treated mouse colon cancer organoids

Project description:To profile transcriptomic alterations induced by catecholamine stimulation, we treated ApcΔ/Δ, KrasG12D/Δ, Trp53Δ/Δ mouse colon cancer organoids with norepinephrine or vehicle and then performed RNA sequencing.

2024-07-30 | GSE243326 | GEO

Establishment of an ulcerative colitis model using colon organoids derived from human induced pluripotent stem cells

Project description:The etiology of inflammatory bowel disease (IBD) is complex, with much room for a greater understanding and development of improved therapies. Therefore, establishing a reliable IBD model is crucial for future advancements. In this study, human induced pluripotent stem (iPS) cell-derived colon organoids (hiPSC-COs) were treated with a combination of TNF-α, IFN-γ, and IL-1β (3 cytokines: 3CK), known to elevate in the serum of IBD patients. Inflammatory responses in stromal cells and damage to intestinal epithelial cells were observed in the 3CK-treated hiPSC-COs. Comparison of molecular signatures of 3CK-treated hiPSC-COs with those of ulcerative colitis (UC) patient’s colon revealed that 3CK-treated hiPSC-COs resemble UC patient’s colon. Furthermore, the elevated production of inflammatory cytokines observed in 3CK-treated hiPSC-COs was attenuated by treatment with tofacitinib. Our UC model will be an essential tool to understand its pathologic mechanisms and identify effective therapeutic approaches.

2024-09-22 | GSE244981 | GEO

RNAseq of patient-derived colon organoids treated with 3PO for 24h

Project description:RNAseq of patient-derived colon organoids treated with 3PO for 24h

| PRJNA1125411 | ENA

RNA sequencing of norepinephrine- or vehicle-treated mouse colon cancer organoids

Project description:RNA sequencing of norepinephrine- or vehicle-treated mouse colon cancer organoids

| PRJNA1017829 | ENA